127 related articles for article (PubMed ID: 28249914)
1. Downregulation of YAP in Clear Cell Renal Cell Carcinoma Contributes to Poor Prognosis and Progressive Features.
Hu X; Chen J; Fu Q
Ann Clin Lab Sci; 2017 Jan; 47(1):36-39. PubMed ID: 28249914
[TBL] [Abstract][Full Text] [Related]
2. YAP is overexpressed in clear cell renal cell carcinoma and its knockdown reduces cell proliferation and induces cell cycle arrest and apoptosis.
Cao JJ; Zhao XM; Wang DL; Chen KH; Sheng X; Li WB; Li MC; Liu WJ; He J
Oncol Rep; 2014 Oct; 32(4):1594-600. PubMed ID: 25175178
[TBL] [Abstract][Full Text] [Related]
3. A feed-forward loop between lncARSR and YAP activity promotes expansion of renal tumour-initiating cells.
Qu L; Wu Z; Li Y; Xu Z; Liu B; Liu F; Bao Y; Wu D; Liu J; Wang A; Chu X; Sun Y; Chen C; Zhang Z; Wang L
Nat Commun; 2016 Nov; 7():12692. PubMed ID: 27886176
[TBL] [Abstract][Full Text] [Related]
4. RNA-binding protein QKI regulates contact inhibition via Yes-associate protein in ccRCC.
Zhu Z; Wei D; Li X; Wang F; Yan F; Xing Z; Yan Z; Lu H; Zhai D; Ye Z; Zhang G; Meng P; Zheng Y; Yuan J; Lu Z; Yuan J
Acta Biochim Biophys Sin (Shanghai); 2019 Jan; 51(1):9-19. PubMed ID: 30566575
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA TUG1 promotes cell proliferation and migration of renal cell carcinoma via regulation of YAP.
Liu S; Yang Y; Wang W; Pan X
J Cell Biochem; 2018 Dec; 119(12):9694-9706. PubMed ID: 30132963
[TBL] [Abstract][Full Text] [Related]
6. Leukemia Inhibitory Factor Receptor Suppresses the Metastasis of Clear Cell Renal Cell Carcinoma Through Negative Regulation of the Yes-Associated Protein.
Lei C; Lv S; Wang H; Liu C; Zhai Q; Wang S; Cai G; Lu D; Sun Z; Wei Q
DNA Cell Biol; 2018 Aug; 37(8):659-669. PubMed ID: 29902078
[TBL] [Abstract][Full Text] [Related]
7. NR1B2 suppress kidney renal clear cell carcinoma (KIRC) progression by regulation of LATS 1/2-YAP signaling.
Yin L; Li W; Wang G; Shi H; Wang K; Yang H; Peng B
J Exp Clin Cancer Res; 2019 Aug; 38(1):343. PubMed ID: 31391070
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA PCAT1 drives clear cell renal cell carcinoma by upregulating YAP via sponging miR-656 and miR-539.
Wang R; Zheng B; Liu H; Wan X
Cell Cycle; 2020 May; 19(10):1122-1131. PubMed ID: 32286142
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the YAP1 oncogene in clear cell renal cell carcinoma is associated with poor outcome.
Rybarczyk A; Klacz J; Wronska A; Matuszewski M; Kmiec Z; Wierzbicki PM
Oncol Rep; 2017 Jul; 38(1):427-439. PubMed ID: 28504812
[TBL] [Abstract][Full Text] [Related]
10. 6-Gingerol suppresses tumor cell metastasis by increasing YAP
Xu S; Zhang H; Liu T; Wang Z; Yang W; Hou T; Wang X; He D; Zheng P
J Biochem Mol Toxicol; 2021 Jan; 35(1):e22609. PubMed ID: 32926756
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of SAV1 plays a role in pathogenesis of high-grade clear cell renal cell carcinoma.
Matsuura K; Nakada C; Mashio M; Narimatsu T; Yoshimoto T; Tanigawa M; Tsukamoto Y; Hijiya N; Takeuchi I; Nomura T; Sato F; Mimata H; Seto M; Moriyama M
BMC Cancer; 2011 Dec; 11():523. PubMed ID: 22185343
[TBL] [Abstract][Full Text] [Related]
12. miR-10b suppresses cell invasion and metastasis through targeting HOXA3 regulated by FAK/YAP signaling pathway in clear-cell renal cell carcinoma.
He C; Chen ZY; Li Y; Yang ZQ; Zeng F; Cui Y; He Y; Chen JB; Chen HQ
BMC Nephrol; 2019 Apr; 20(1):127. PubMed ID: 30975094
[TBL] [Abstract][Full Text] [Related]
13. Decreased SATB2 expression is associated with metastasis and poor prognosis in human clear cell renal cell carcinoma.
Guo C; Xiong D; Yao X; Gu W; Zhang H; Yang B; Peng B; Liu M; Zheng J
Int J Clin Exp Pathol; 2015; 8(4):3710-8. PubMed ID: 26097552
[TBL] [Abstract][Full Text] [Related]
14. Expression of PGAM1 in renal clear cell carcinoma and its clinical significance.
Li C; Shu F; Lei B; Lv D; Zhang S; Mao X
Int J Clin Exp Pathol; 2015; 8(8):9410-5. PubMed ID: 26464696
[TBL] [Abstract][Full Text] [Related]
15. hZIP1 that is down-regulated in clear cell renal cell carcinoma is negatively associated with the malignant potential of the tumor.
Dong X; Kong C; Zhang Z; Liu X; Zhan B; Chen Z; Shi D
Urol Oncol; 2014 Aug; 32(6):885-92. PubMed ID: 24878177
[TBL] [Abstract][Full Text] [Related]
16. The Immunoexpression of YAP1 and LATS1 Proteins in Clear Cell Renal Cell Carcinoma: Impact on Patients' Survival.
Godlewski J; Kiezun J; Krazinski BE; Kozielec Z; Wierzbicki PM; Kmiec Z
Biomed Res Int; 2018; 2018():2653623. PubMed ID: 29850494
[TBL] [Abstract][Full Text] [Related]
17. RALY RNA binding protein-like reduced expression is associated with poor prognosis in clear cell renal cell carcinoma.
Cui ZW; Xia Y; Ye YW; Jiang ZM; Wang YD; Wu JT; Sun L; Zhao J; Fa PP; Sun XJ; Gui YT; Cai ZM
Asian Pac J Cancer Prev; 2012; 13(7):3403-8. PubMed ID: 22994768
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder.
Liu JY; Li YH; Lin HX; Liao YJ; Mai SJ; Liu ZW; Zhang ZL; Jiang LJ; Zhang JX; Kung HF; Zeng YX; Zhou FJ; Xie D
BMC Cancer; 2013 Jul; 13():349. PubMed ID: 23870412
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of the pro-apoptotic XIAP associated factor-1 (XAF1) during progression of clear-cell renal cancer.
Kempkensteffen C; Fritzsche FR; Johannsen M; Weikert S; Hinz S; Dietel M; Riener MO; Moch H; Jung K; Krause H; Miller K; Kristiansen G
BMC Cancer; 2009 Aug; 9():276. PubMed ID: 19664236
[TBL] [Abstract][Full Text] [Related]
20. LIM and SH3 domain protein 1 (LASP-1) overexpression was associated with aggressive phenotype and poor prognosis in clear cell renal cell cancer.
Yang F; Zhou X; Du S; Zhao Y; Ren W; Deng Q; Wang F; Yuan J
PLoS One; 2014; 9(6):e100557. PubMed ID: 24955835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
